Core Viewpoint - Anhui QuanYin High-Tech Seed Industry Co., Ltd. (stock code: 300087) has received a notice from the China Securities Regulatory Commission (CSRC) regarding a formal investigation for suspected violations of information disclosure laws [1][6]. Group 1: Company Announcement - On January 30, 2026, the company announced that it received the CSRC's notice of investigation (No. 0232026002) due to alleged violations of information disclosure regulations [1][6]. - The company stated that its production and operational activities are currently normal and that the investigation is not expected to have a significant impact on its operations [1][6]. Group 2: Investor Compensation - Investors who purchased shares of Anhui QuanYin High-Tech (300087) before or on January 30, 2026, and held them through the close of trading on that date, may be eligible to prepare for compensation claims if they incurred losses [2][6]. - The preliminary conditions for compensation include having a trading statement of the shares, a copy of the investor's ID, and a securities account information query form, all of which must be stamped by the brokerage [2][4][8].

Core Viewpoint - Jiangsu Baoxin Technology Co., Ltd. (stock code: 002514) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation for suspected violations of information disclosure laws [1][6]. Group 1: Investigation Details - The CSRC has decided to initiate an investigation against the company and its actual controller, Ma Wei, due to alleged violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][6]. - Baoxin Technology stated that during the investigation, it will actively cooperate with the CSRC and comply with regulatory disclosure requirements [2][6]. Group 2: Impact on Operations - The company emphasized that Ma Wei does not hold any position within the company and that all production and operational activities are proceeding normally, indicating that the investigation has not affected the company's regular operations [2][6]. Group 3: Investor Rights and Compensation - Investors who suffered losses due to the alleged violations have the right to seek compensation. According to the Securities Law and related judicial interpretations, investors can file lawsuits for damages caused by false statements [2][6]. - Preliminary compensation conditions state that investors who purchased Baoxin Technology shares before or on January 30, 2026, and still hold them after the market close on that date, may prepare for compensation claims [7]. Group 4: Required Documentation for Claims - Investors need to prepare the following documents for compensation claims: 1. Original transaction statements for Baoxin Technology shares, stamped by the brokerage [7]. 2. A photocopy of the investor's ID card [8]. 3. An original securities account information query form, also stamped by the brokerage [9].

Core Viewpoint - The legal proceedings against Zhongzhuang Construction (002822) have progressed, with investors winning a first-instance judgment in a lawsuit related to false statements made by the company [1][2]. Group 1: Legal Developments - Zhongzhuang Construction has faced a lawsuit for false statements, leading to a recent ruling by the Shenzhen Intermediate People's Court in favor of investors [1]. - The law firm representing the investors continues to accept claims from other investors affected by the company's actions [1]. Group 2: Financial Misconduct - Zhongzhuang Construction and its subsidiary were found to have misrepresented financial data by underreporting costs and inflating profits from 2017 to 2021, with inflated profit amounts of 18.33 million, 12.92 million, 43.99 million, 13.02 million, and 16.10 million respectively, which constituted 9.06%, 5.26%, 14.74%, 3.91%, and 8.88% of the reported profits for those years [2]. - The company issued several financial documents during this period that included the inflated figures, which contributed to the legal issues it now faces [2]. Group 3: Investor Claims - Investors who purchased Zhongzhuang Construction stock between April 16, 2018, and December 16, 2023, and sold or held the stock after December 16, 2023, are eligible to file claims [3]. - The law firm has a history of successfully representing investors in similar cases, with many achieving settlements or victories [3].

Core Viewpoint - The article discusses the ongoing legal issues faced by Haiyue Energy (600387) due to violations related to the misuse of funds and accounting errors, leading to investor compensation claims and regulatory penalties [1][2][3]. Group 1: Legal and Regulatory Issues - Haiyue Energy has been penalized by the China Securities Regulatory Commission (CSRC) for failing to disclose non-operating fund occupation by its controlling shareholder, Gaoxin Jinkong [1][2]. - Between 2021 and 2022, Haiyue Energy transferred funds to its controlling shareholder through prepayments to suppliers, constituting non-operating fund occupation, with amounts reaching up to 68.8 million yuan in 2022 [2][5]. - The company did not timely disclose these fund occupations in its financial reports for 2021 and 2022, leading to incomplete and inaccurate disclosures [5][6]. Group 2: Financial Reporting Errors - Haiyue Energy acknowledged accounting errors in its 2022 semi-annual report, resulting in an inflated revenue and cost figure of 302.08 million yuan, which represented 49.33% and 50.51% of the reported figures respectively [3][6]. - The company used the total amount method incorrectly for revenue recognition, leading to significant discrepancies in its financial statements [6]. Group 3: Investor Compensation - Investors affected by Haiyue Energy's issues can still file compensation claims, with ongoing efforts by legal teams to assist in these cases [1][4]. - The law firm representing investors has indicated that those who purchased shares between August 31, 2021, and April 29, 2023, may still be eligible for claims if they sell or hold their shares after the specified dates [6].

Core Viewpoint - ST Cuihua is facing significant liquidity issues and has been subjected to an investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws [1][2][3][4]. Group 1: Regulatory Actions - ST Cuihua received a notice from the CSRC regarding an investigation due to suspected violations of information disclosure laws, leading to a formal case being opened [1][3]. - The company is under scrutiny as it has been accused of failing to comply with the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][3]. Group 2: Financial Difficulties - As of February 6, 2026, ST Cuihua and its subsidiaries had 45 bank accounts frozen due to contract disputes and overdue loans, which include 4 basic accounts and 41 general accounts [2][4]. - The company reported overdue principal loans amounting to 254 million yuan, resulting in multiple lawsuits and arbitration from financial institutions, severely impacting its operations [2][4]. Group 3: Performance Forecast - On January 31, 2026, ST Cuihua announced its 2025 annual performance forecast, estimating a net profit attributable to shareholders of 21 million to 31 million yuan, representing a year-on-year decrease of 85.69% to 90.31% [5]. - The company also projected a net profit excluding non-recurring gains and losses to be between 162 million and 242 million yuan, indicating a year-on-year increase of 154.81% to 280.64% [5].

Group 1 - The financing balance of Quanyin High-Tech reached 403 million, accounting for 5.25% of its market capitalization as of February 5 [2] - On January 30, Quanyin High-Tech announced that it received a notice of investigation from the China Securities Regulatory Commission, indicating potential legal implications for investors who suffered losses due to inaccurate disclosures [3] - Investors who purchased Quanyin High-Tech shares between the IPO and January 30, 2026, and held them until the closing on January 30, 2026, are eligible to participate in compensation claims [3] Group 2 - On December 15, 2025, Quanyin High-Tech held a board meeting to approve the nomination of Jiang Yekui as a non-independent director, pending shareholder approval [4][5] - Jiang Yekui, born in May 1982, currently serves as the Vice President of Syngenta Group China and has held various significant positions in government and corporate sectors [6] - Jiang Yekui does not hold any shares in the company and has no conflicts of interest with major shareholders or other board members, meeting all legal and regulatory requirements for directorship [7] Group 3 - Quanyin High-Tech holds 72 patents and has obtained 19,313 administrative licenses, indicating a strong position in intellectual property and regulatory compliance [8]

Core Viewpoint - Century Huatong has been found guilty of multiple violations related to false reporting of goodwill in its annual reports from 2018 to 2022, leading to potential legal actions from investors [2][4]. Group 1: Violations and Penalties - The company failed to conduct goodwill impairment tests as required, resulting in an underreporting of goodwill impairment provisions by 62.363 million yuan in 2018 [5]. - There were errors in the disclosure of goodwill values in annual reports from 2019 to 2022, and the reporting segments did not comply with accounting standards [6]. - The company also did not perform required goodwill impairment tests for 2020 and 2022, leading to inflated or deflated profits [6]. Group 2: Investor Claims - Investors who purchased Century Huatong shares between April 27, 2019, and July 25, 2023, and sold or continued to hold the shares after July 25, 2023, may still initiate claims, but the time for doing so is limited to approximately five months [6]. - The law firm representing the investors has successfully secured compensation for multiple batches of claims in the past [3].

Core Viewpoint - The recent developments regarding Weichuang Co., Ltd. (威创股份) indicate significant legal and regulatory challenges due to false statements and information disclosure violations, leading to investor compensation claims and potential further legal actions. Group 1: Legal Developments - On February 3, 2026, Weichuang announced a major lawsuit ruling, where the company was ordered to compensate an investor a total of 116,550.88 yuan for investment losses, commissions, and stamp duties, with certain individuals held jointly liable for this debt [1][4]. - The law firm representing the investors, led by attorney Xu Feng, noted that this ruling signifies a first-instance victory for investors, and those meeting specific criteria may continue to file lawsuits [1][4]. Group 2: Regulatory Violations - On February 21, 2025, Weichuang received an administrative penalty decision from the Guangdong Regulatory Bureau of the China Securities Regulatory Commission, revealing multiple violations of information disclosure regulations [2][5]. - Specific violations included failure to disclose changes in actual control, late reporting of acquisition agreements, and false records in the 2023 semi-annual and third-quarter reports regarding non-operating fund occupations and transactions with related parties [2][3][5]. Group 3: Investor Compensation Opportunities - Investors who purchased Weichuang shares between June 21, 2023, and December 23, 2023, and sold or held the shares after December 23, 2023, are eligible to initiate compensation claims [3][5].

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、实控人被立案调查 2月5日，倍轻松（维权）发布公告称，公司于2月4日收到证监会对实际控制人马学军下发的《立案告知 书》，因其涉嫌操纵证券市场，证监会决定对其立案。 倍轻松表示，本次调查事项系对马学军个人的调查，不会对公司的日常运营造成重大影响，其本人仍在 公司正常履职。目前公司各项经营活动和业务均正常开展。 此外该公司还被立案调查中，倍轻松于12月25日晚发布公告称公司及实际控制人因涉嫌信息披露违法违 规，被中国证监会立案调查。根据历史案例，上市公司一旦被证监会立案调查，最终被认定为信息披露 违法违规并受到处罚的可能性较大。 二、投资者维权要求 梳理过往公告发现，2025年8月2日，公司就曾自查发现实控人在以往年度存在通过员工借款、提前支付 供应商采购款等方式占用公司资金的行为。立案调查或与实控人不断侵占上市公司资金有关。 信息披露义务人在证券交易 ...

Core Viewpoint - The company, Jushi Chemical, has been found guilty of financial fraud, inflating its revenue and costs in its 2023 semi-annual report, leading to significant penalties and potential investor claims [1][3]. Group 1: Financial Fraud Details - Jushi Chemical inflated its revenue by 157 million yuan and its operating costs by 158 million yuan in the first half of 2023 [1][3]. - The company utilized three main methods for inflating its financial figures, including engaging in fictitious trades with controlled companies, manipulating trade chains, and reporting sales of goods that were never actually shipped [5]. - The inflated figures represented 8.32% of total revenue, 8.51% of total costs, and resulted in a profit reduction of 166.29 million yuan, accounting for 6.81% of total profit [5]. Group 2: Investor Claims - Investors who purchased Jushi Chemical shares between August 29, 2023, and November 21, 2025, and suffered losses are eligible to file claims [3]. - The formal penalties serve as strong evidence for investors seeking compensation for their losses due to the company's fraudulent activities [3]. Group 3: Company Performance Outlook - Jushi Chemical has been experiencing deteriorating business conditions, with projections indicating a significant decline in performance for 2024 and 2025 [7]. - The company is expected to report a net loss of between 90 million and 120 million yuan for the year 2025, marking its second consecutive year of losses [7]. - The decline in revenue is attributed to a significant drop in the liquefied petroleum gas business, heavily influenced by fluctuations in international crude oil prices [7].